Drivers of cancer metastasis - Arise early and remain present

Biochim Biophys Acta Rev Cancer. 2024 Mar;1879(2):189060. doi: 10.1016/j.bbcan.2023.189060. Epub 2023 Dec 25.

Abstract

Cancer and its metastases arise from mutations of genes, drivers that promote a tumor's growth. Analyses of driver events provide insights into cancer cell history and may lead to a better understanding of oncogenesis. We reviewed 27 metastatic research studies, including pan-cancer studies, individual cancer studies, and phylogenetic analyses, and summarized our current knowledge of metastatic drivers. All of the analyzed studies had a high level of consistency of driver mutations between primary tumors and metastasis, indicating that most drivers appear early in cancer progression and are maintained in metastatic cells. Additionally, we reviewed data from around 50,000 metastatic cancer patients and compiled a list of genes altered in metastatic lesions. We performed Gene Ontology analysis and confirmed that the most significantly enriched processes in metastatic lesions were the epigenetic regulation of gene expression, signal transduction, cell cycle, programmed cell death, DNA damage, hypoxia and EMT. In this review, we explore the most recent discoveries regarding genetic factors in the advancement of cancer, specifically those that drive metastasis.

Keywords: Drivers; Genomic profiling; Metastasis; Molecular screening; Mutations; cancer.

Publication types

  • Review

MeSH terms

  • Carcinogenesis / genetics
  • Cell Transformation, Neoplastic / genetics
  • Epigenesis, Genetic*
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Phylogeny